Skip to main content

Lumbar Spine Fusion for Degenerative Disease, 1-3 Levels Measure

CBE ID
3626
1.4 Project
Endorsement Status
1.1 New or Maintenance
Previous Endorsement Cycle
Is Under Review
No
Next Maintenance Cycle
Spring 2026
1.3 Measure Description

The Lumbar Spine Fusion for Degenerative Disease, 1-3 Levels episode-based cost measure evaluates a clinician’s risk-adjusted cost to Medicare for patients who undergo surgery for lumbar spine fusion during the performance period. The measure score is the clinician’s risk-adjusted cost for the episode group averaged across all episodes attributed to the clinician. This procedural measure includes costs of services that are clinically related to the attributed clinician’s role in managing care during each episode from 30 days prior to the clinical event that opens, or “triggers,” the episode through 90 days after the trigger. Patient populations eligible for Lumbar Spine Fusion for Degenerative Disease, 1-3 Levels measure include Medicare beneficiaries enrolled in Medicare Parts A and B.